Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.340
+0.030 (1.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dogwood Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -5.73 | -5.3 | -12.25 | -15.96 | -10.35 | -2.47 | |
| Other Amortization | - | - | - | - | 0.05 | 0.06 | |
| Stock-Based Compensation | 0.53 | 0.62 | 0.58 | 0.32 | 7.43 | - | |
| Provision & Write-off of Bad Debts | - | - | - | - | -0.02 | 0 | |
| Other Operating Activities | - | - | - | - | -0.04 | - | |
| Change in Accounts Payable | 0.25 | -0.46 | 0.22 | 0.27 | 0.05 | -0.09 | |
| Change in Other Net Operating Assets | 0.82 | 0.27 | -0.02 | -0.32 | -1.03 | 0.41 | |
| Operating Cash Flow | -4.13 | -4.87 | -11.47 | -15.69 | -3.9 | -2.09 | |
| Long-Term Debt Issued | - | - | - | - | 1.99 | 2.43 | |
| Net Debt Issued (Repaid) | - | - | - | - | 1.99 | 2.43 | |
| Issuance of Common Stock | 1.38 | 1.16 | 4.49 | 0.2 | 31.53 | - | |
| Other Financing Activities | - | - | - | -0.3 | -0.06 | -0.06 | |
| Financing Cash Flow | 1.38 | 1.16 | 4.49 | -0.1 | 33.38 | 2.37 | |
| Net Cash Flow | -2.75 | -3.71 | -6.98 | -15.79 | 29.49 | 0.28 | |
| Free Cash Flow | -4.13 | -4.87 | -11.47 | -15.69 | -3.9 | -2.09 | |
| Free Cash Flow Per Share | -4.63 | -6.48 | -25.90 | -47.09 | -19.76 | -10.82 | |
| Cash Interest Paid | - | - | - | - | 0.01 | - | |
| Levered Free Cash Flow | -2.04 | -2.98 | -6.92 | -9.8 | -0.77 | -1.18 | |
| Unlevered Free Cash Flow | -2.04 | -2.98 | -6.92 | -9.8 | -0.53 | -1 | |
| Change in Net Working Capital | -1.07 | 0.19 | -0.2 | 0.35 | 1.76 | -0.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.